Guoyuan International issued a research report on Essex Bio-Technology on 1 April 2026. Essex posted steady operating performance growth in…
Browsing: HealthCare
Formerra, a leading distributor of performance materials, today announced a global price increase of $0.02 / lb on all products.…
Across the landscape of global biotech companies, the appointment of a senior executive often serves as a “barometer”—offering insights into…
On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group’s total…
China’s 2026 Report on the Work of the Government identified biopharmaceuticals as an emerging pillar industry, underscoring a supportive policy…
TruMerit-led report highlights innovative staffing models, technology-enabled care, and team-based approaches to strengthen health systems worldwide. A new international report…
On 27 March, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK, hereinafter referred to as Ausnutria or the Company) officially released…
RESULTS HIGHLIGHTS: – The Revenue for the year ended 31 December 2025 was approximately HK$3,736.5 million, representing an increase of…
– Annual sales of HuaTangNing exceeded 4 million packs, a year-on-year increase of 91%, with revenues reaching RMB 492.9 million,…
– Innovation and R&D Advance Steadily, RMB 31.83 Billion in Revenue Recorded – Underlying Profit Attributable to Owners of the…
Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across…
On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its…
Wellgistics Health, Inc. (Wellgistics or the Company) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of…
– Multiple Regulatory Approvals and Strategic Collaborations Strengthened Market Position Key Results Highlights: – Revenue Growth: 8.6% increase to approximately HK$1,813.8…
Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited (CORXEL).…
Pacific Avenue Capital Partners (Pacific Avenue), a Los Angeles-headquartered private equity firm focused on corporate carve-outs and other complex transactions…
March 9, Everest Medicines (HKG: 1952) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by…
International Women’s Day: Why Menopause May Be a Missed Cardiovascular Risk Window As International Women’s Day prompts renewed focus on…
Formerra, LLC (Formerra), a leading distributor of engineered thermoplastic resins, additives, elastomers, and other specialty materials, today announced the appointment…
– First glucokinase-activator (GKA) approval outside mainland China – Approval supports a differentiated approach to Type 2 diabetes (T2D) management…